Bruce Ganem is Franz and Elisabeth Roessler Professor of Chemistry in the Department of Chemistry and Chemical Biology at Cornell University. After completing graduate study at Columbia University and postdoctoral work at Stanford, he joined the Cornell faculty in 1974, and served as department chairman from 1993 to 1997.
Professor Ganem's broad scientific research interests and accomplishments involve the emerging interfaces of organic, analytical, and biological chemistry with biochemistry and molecular medicine, including medicinal chemistry, structure-based drug design, protein engineering, and biotechnology.
Dr. Ganem has received numerous awards and fellowships, including the Catalyst Award from the Chemical Manufacturers Association and the Cope Scholar Award from the American Chemical Society. He is the author of some 200 scientific papers, and consults for several pharmaceutical and biotechnology companies. He presently serves as a member of the Scientific Advisory Boards of ArQule, Inc, LeukoSite, Inc., Sorvall, Inc., and Taktix Pharmaceuticals.
Bruce Ganem received his undergraduate degree from Harvard College and his Ph.D. from Columbia University.
I would just take your question and turn it around. Yes, there are things slipping between the cracks in VC's. And that's a great opportunity for scientists and engineers. You don't have to be your own entrepreneur. Some terrific scientists have had careers joining VC firms. Becoming partners, ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
John Callister Discusses Intellectual Property Issues In Mechanical Engineering Field of Noise and Vibration Control
Bruce Ganem Discusses Challenges That Scientists Face In Invention of Product Versus Execution of a Company
John Callister States Importance of Understanding That Products Must Generate a Positive Cash Flow
Dan Huttenlocher States Technical People Are Better At Understanding and Stating The Problem
